- Home
- WEAV vs CYRX Comparison
WEAV vs CYRX Comparison
Compare WEAV & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WEAV | CYRX |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.3M | 472.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | WEAV | CYRX |
|---|---|---|
| Price | $6.84 | $10.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $12.20 | ★ $12.83 |
| AVG Volume (30 Days) | ★ 1.4M | 340.6K |
| Earning Date | 02-19-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | $229,790,000.00 | ★ $243,795,000.00 |
| Revenue This Year | $19.22 | N/A |
| Revenue Next Year | $15.10 | $9.27 |
| P/E Ratio | ★ N/A | $8.65 |
| Revenue Growth | 17.34 | ★ 41.27 |
| 52 Week Low | $5.64 | $4.58 |
| 52 Week High | $17.63 | $11.45 |
Technical Indicators
Market Signals| Indicator | WEAV | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 53.93 |
| Support Level | $6.48 | $10.39 |
| Resistance Level | $7.32 | $11.45 |
| Average True Range (ATR) | 0.30 | 0.49 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 30.20 | 52.14 |
Price Performance
Historical ComparisonAbout WEAV Weave Communications Inc.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.